Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 05:20PM GMT
Release Date Price: R$26 (+3.56%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right. Good afternoon, everybody. I'm Doug Schenkel from Cowen's Life Science and Diagnostic Tools team. It's our pleasure to welcome Prahlad Singh, PKI's President and CEO, to our conference.

For those of you who may be a bit new to the PerkinElmer story, just a little bit of background on Prahlad. He was elected President and Chief Executive Officer of PerkinElmer, I think that was in December of 2019. Prior to that, he was in important leadership positions within PerkinElmer going back to when he joined the company, I believe, in May 2014. It's been an interesting time for anybody to take over in a new role in leadership. You predated the pandemic by, maybe, weeks.

And as I think we wrote as a title in our last note on PerkinElmer's last earnings call, you've really exemplified doing well by doing good with COVID-19 while using this as an opportunity to not just serve the community, but also to evolve the PerkinElmer portfolio, at least begin to evolve the PerkinElmer portfolio to be a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot